Panbela Therapeutics, Inc. (PBLA)
OTCMKTS · Delayed Price · Currency is USD
0.0065
+0.0055 (550.00%)
Jan 27, 2026, 4:00 PM EST
Panbela Therapeutics Market Cap
Panbela Therapeutics has a market cap or net worth of $31.56 thousand as of January 28, 2026. Its market cap has decreased by -97.96% in one year.
Market Cap
31.56K
Enterprise Value
1.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 19, 2015, Panbela Therapeutics's market cap has decreased from 89.28M to 31.56K, a decrease of -99.96%. That is a compound annual growth rate of -53.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 31.56K | 3,149.95% |
| Dec 31, 2025 | 971.00 | -99.95% |
| Dec 31, 2024 | 1.84M | -70.55% |
| Dec 29, 2023 | 6.27M | 109.12% |
| Dec 30, 2022 | 3.00M | -87.09% |
| Dec 31, 2021 | 23.21M | -32.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |
| MultiCell Technologies | 5.00K |
| Core One Labs | 4.71K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Xeno Transplants | 4.04K |